Intralesional interferon alpha-2b therapy for Buschke-Loewenstein tumour.
DOI:
https://doi.org/10.2340/0001555574457459Abstract
A patient with a Buschke-Loewenstein tumour associated with human papillomavirus type 6/11 is reported. He was intralesionally treated with human recombinant alpha-2b interferon (9 x 10(6) IU/day) three times weekly. The tumour completely disappeared within 5 months of continuous treatment which was well tolerated. Sixteen months after completion of therapy the patient remains well and free of disease.Downloads
Download data is not yet available.
Downloads
Published
1994-11-01
How to Cite
Tsambaos, D., Monastirli, A., Kapranos, N., Georgiou, S., Pasmatzi, E., & Berger, H. (1994). Intralesional interferon alpha-2b therapy for Buschke-Loewenstein tumour. Acta Dermato-Venereologica, 74(6), 457–459. https://doi.org/10.2340/0001555574457459
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
